Improving preparation for scalp cooling: Learning from women undergoing chemotherapy for early-stage breast cancer-The COOL study

被引:3
|
作者
Renehan, Steffi [1 ,2 ]
Tencic, Monika [2 ]
Jackson, Kylie [3 ]
Krishnasamy, Meinir [1 ,4 ,5 ]
机构
[1] Peter MacCallum Canc Ctr, Acad Nursing Unit, Melbourne, Vic 3000, Australia
[2] Univ Melbourne, Dept Nursing, Melbourne, Vic, Australia
[3] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[4] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Dept Nursing, Melbourne, Vic, Australia
[5] Victorian Comprehens Canc Ctr, Melbourne, Vic, Australia
关键词
breast cancer; chemotherapy; co-production; nurse training; patient experience; scalp cooling; INDUCED ALOPECIA; MIXED-METHODS; BODY-IMAGE; HAIR LOSS; PREVENTION; INFORMATION; HYPOTHERMIA; IMPACT; QUESTIONNAIRE; EXPERIENCE;
D O I
10.1111/jocn.16160
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Aims and objectives: This study set out to understand the experiences and expectations of scalp cooling among women with early-stage breast cancer. The objective was to develop patient co-produced information resources to better inform and prepare women considering scalp cooling during chemotherapy. Background: Treatment-induced alopecia is a common concern among women preparing for chemotherapy. Evidence indicates that many women feel inadequately prepared for scalp cooling, resulting in potentially mitigable distress and disappointment. Design: A single-site, sequential, explanatory mixed-methods design was used. Participants included women with early-stage breast cancer who had previously or were currently using, scalp cooling. Women completed an online survey exploring scalp cooling experiences and expectations and self-selecting participants took part in one semi-structured, audio-recorded interview. Guidelines for Good Reporting of a Mixed Methods Study were followed. Results: Forty-nine women (69%) consented to take part in the survey and 23 took part in an interview. Most women described losing more hair than they expected. Many described feeling inadequately prepared for the discomfort of scalp cooling; the additional time needed to accommodate scalp cooling during treatment and, that they lacked information about self-care to help minimise hair loss. Importantly, several participants described variability in nurses' knowledge and practical skills regarding scalp cooling. Conclusions: To optimise experience of scalp cooling, women need comprehensive preparatory information about variability in efficacy of scalp cooling; time needed to accommodate scalp cooling; hair care during treatment, and the potential discomfort associated with it. They also need nurses to be confident and well informed about scalp cooling processes. Relevance to clinical practice: Our study led to the development of online, patient co-produced resources to help prepare and inform women considering using scalp cooling; and an online scalp cooling training module and checklist for nurses. Links to the resources are included in the manuscript.
引用
收藏
页码:3222 / 3234
页数:13
相关论文
共 50 条
  • [31] Adherence to Intravenous Chemotherapy in African American and White Women With Early-Stage Breast Cancer
    Wells, Jessica S.
    Strickland, Ora L.
    Dalton, Jo Ann
    Freeman, Sarah
    CANCER NURSING, 2015, 38 (02) : 89 - 98
  • [32] Efficacy of Scalp Cooling in Preventing and Recovering From Chemotherapy-Induced Alopecia in Breast Cancer Patients: The HOPE Study
    Kinoshita, Takayuki
    Nakayama, Takahiro
    Fukuma, Eisuke
    Inokuchi, Masafumi
    Ishiguro, Hiroshi
    Ogo, Etsuyo
    Kikuchi, Mari
    Jinno, Hiromitsu
    Yamazaki, Naoya
    Toi, Masakazu
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [33] Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study
    Giarratano, Tommaso
    Frezzini, Simona
    Zanocco, Monica
    Giorgi, Carlo Alberto
    Mioranza, Eleonora
    Miglietta, Federica
    Griguolo, Gaia
    Falci, Cristina
    Faggioni, Giovanni
    Tasca, Giulia
    Di Liso, Elisabetta
    Vernaci, Grazia
    Menichetti, Alice
    Mantiero, Mara
    Grosso, Daniela
    Guarneri, Valentina
    Dieci, Maria Vittoria
    BREAST JOURNAL, 2020, 26 (07) : 1296 - 1301
  • [34] Sexual functioning in women after mastectomy versus breast conserving therapy for early-stage breast cancer: A prospective controlled study
    Aerts, L.
    Christiaens, M. R.
    Enzlin, P.
    Neven, P.
    Amant, F.
    BREAST, 2014, 23 (05) : 629 - 636
  • [35] Outcomes of women with early-stage breast cancer receiving adjuvant trastuzumab
    Seal, M. D.
    Speers, C. H.
    O'Reilly, S.
    Gelmon, K. A.
    Ellard, S. L.
    Chia, S. K.
    CURRENT ONCOLOGY, 2012, 19 (04) : 197 - 201
  • [36] Online accounts of gene expression profiling in early-stage breast cancer: Interpreting genomic testing for chemotherapy decision making
    Ross, Emily
    Swallow, Julia
    Kerr, Anne
    Cunningham-Burley, Sarah
    HEALTH EXPECTATIONS, 2019, 22 (01) : 74 - 82
  • [37] Serum selenium measurements in women with early-stage breast cancer with and without chemotherapy-induced ovarian failure
    Hollie A. Breedlove
    Anne M. Smith
    Raymond F. Burk
    Kristina E. Hill
    Charles L. Shapiro
    Breast Cancer Research and Treatment, 2006, 97 : 225 - 230
  • [38] Patients’ preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?
    S J T Jansen
    J Kievit
    M A Nooij
    J C J M de Haes
    I M E Overpelt
    H van Slooten
    E Maartense
    A M Stiggelbout
    British Journal of Cancer, 2001, 84 : 1577 - 1585
  • [39] Yoga Therapy During Chemotherapy for Early-Stage and Locally Advanced Breast Cancer
    Greaney, Samantha K.
    Amin, Neha
    Prudner, Bethany C.
    Compernolle, Maggie
    Sandell, Linda J.
    Tebb, Susan C.
    Weilbaecher, Katherine N.
    Abeln, Peri
    Luo, Jingqin
    Tao, Yu
    Hirbe, Angela C.
    Peterson, Lindsay L.
    INTEGRATIVE CANCER THERAPIES, 2022, 21
  • [40] Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?
    Jansen, SJT
    Kievit, J
    Nooij, MA
    de Haes, JCJM
    Overpelt, IME
    van Slooten, H
    Maartense, E
    Stiggelbout, AM
    BRITISH JOURNAL OF CANCER, 2001, 84 (12) : 1577 - 1585